Bottom line
How much do PBE and SHPAX overlap?
26% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 29.9% of PBE's assets and 29.9% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings PBE and SHPAX have in common
| Holding | % of PBE | % of SHPAX | Overlap |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 5.47% | 3.93% | 3.93% |
| Amgen Inc. | 5.22% | 5.04% | 5.04% |
| Vertex Pharmaceuticals Inc. | 4.99% | 3.36% | 3.36% |
| Gilead Sciences, Inc. | 4.43% | 3.94% | 3.94% |
| United Therapeutics Corp. | 4.08% | 6.17% | 4.08% |
| Incyte Corp. | 3.06% | 2.89% | 2.89% |
| Exelixis, Inc. | 2.64% | 4.55% | 2.64% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PBE
- Invesco Private Prime Fund — 12.89%
- CareDx, Inc. — 5.04%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Bio-Techne Corp. — 3.73%
- Illumina, Inc. — 3.51%
- Protagonist Therapeutics, Inc. — 3.40%
- Vericel Corp. — 3.27%
- Alnylam Pharmaceuticals, Inc. — 3.17%
- Repligen Corp. — 3.04%
- Acadia Pharmaceuticals Inc. — 3.02%
- Halozyme Therapeutics, Inc. — 2.98%
- Qiagen N.V. — 2.89%
- BioMarin Pharmaceutical Inc. — 2.82%
Only in SHPAX
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Johnson & Johnson — 3.91%
- National Healthcare Corp — 3.72%
- Merck & Company Inc — 3.63%
- Cigna Group (the) — 3.63%
- Medpace Holdings Inc — 3.37%
- Intuitive Surgical Inc — 3.14%
- Bristol-myers Squibb Company — 3.07%
- Stryker Corp — 2.40%
- Medtronic Plc — 2.20%
Asset mix
| Asset type | PBE | SHPAX |
|---|---|---|
| Stocks | 100.1% | 99.0% |
| Cash & short-term funds | 17.9% | 1.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | PBE | SHPAX |
|---|---|---|
| US | 108.6% | 86.1% |
| IE | — | 8.4% |
| GB | 4.9% | — |
| CH | — | 4.5% |
| NL | 2.9% | — |
| KY | 1.6% | — |
| DK | — | 1.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PBE and SHPAX overlap?
What stocks do PBE and SHPAX have in common?
Should I own both PBE and SHPAX?
Which holds more stocks, PBE or SHPAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.